(19)
(11) EP 3 503 965 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
09.03.2022 Bulletin 2022/10

(45) Mention of the grant of the patent:
26.01.2022 Bulletin 2022/04

(21) Application number: 17757767.3

(22) Date of filing: 25.08.2017
(51) International Patent Classification (IPC): 
A61N 1/36(2006.01)
(52) Cooperative Patent Classification (CPC):
A61N 1/36057; A61N 1/36114
(86) International application number:
PCT/EP2017/071475
(87) International publication number:
WO 2018/037127 (01.03.2018 Gazette 2018/09)

(54)

TREATMENT OF CARDIAC DYSFUNCTION

BEHANDLUNG VON HERZFUNKTIONSSTÖRUNGEN

TRAITEMENT DES DYSFONCTIONNEMENTS CARDIAQUES

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 26.08.2016 US 201662379937 P

(43) Date of publication of application:
03.07.2019 Bulletin 2019/27

(60) Divisional application:
22153040.5

(73) Proprietors:
  • The Regents of the University of California
    Oakland, CA 94607-5200 (US)
  • Presidio Medical, Inc.
    South San Francisco, CA 94080 (US)

(72) Inventors:
  • ARDELL, Jeffrey Laurence
    Oakland California 94607-5200 (US)
  • SHIVKUMAR, Kalyanam
    Oakland California 94607-5200 (US)
  • SRIDHAR, Arun
    Stevenage Hertfordshire SG1 2NY (GB)

(74) Representative: Carpmaels & Ransford LLP 
One Southampton Row
London WC1B 5HA
London WC1B 5HA (GB)


(56) References cited: : 
WO-A2-2007/059362
US-A1- 2005 149 146
US-A1- 2007 191 895
US-A1- 2011 257 708
US-A1- 2013 238 048
US-A1- 2015 005 680
US-A1- 2015 374 995
US-B1- 6 937 896
US-B1- 7 139 607
 US-A1- 2005 065 575
US-A1- 2006 206 159
US-A1- 2007 191 895
US-A1- 2013 073 008
US-A1- 2014 288 551
US-A1- 2015 223 746
US-A1- 2016 101 289
US-B1- 6 973 350
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).